PATIENT APP FOR
COLORECTAL CANCER

A comprehensive app that empowers patients with valuable insights and deeper understanding and knowledge of their disease. Co-funded and supported by the European Commission and close advocates.

Co-funded by the
European Union

FEATURES

Analysis of patient’s
medical records
Information
on side effects of
the drug therapies
Scientific
evidence based on
the mutation
List of doctors for
the second opinion
Clinical
trial matching
Community
forum

DON'T MISS YOUR CHANCE AND
PRE-REGISTER FOR A FREE TRIAL TODAY!

Inspiration

This CRC Application was inspired by our co-founder Mark Rogers, who lost his own battle with Colorectal cancer in March 2022. Every year, nearly 2 million people are diagnosed with the disease and it is our team’s quest to deliver a valuable solution to anyone who has been touched by it.

Research

Arcella partnered with the innovative EU start-up, Real-Research, to discover new combination therapy for Colorectal cancer while testing an existing blockbuster drug for Multiple Myeloma in a combination with nuclear export inhibitor, that showed effectiveness in destroying colorectal cancer cells from fresh patient-biopsy derived cells. Arcella is on a mission to continue our research to discover more novel and safe drug therapies to support cancer patients.